金斯瑞(01548.HK):傳奇生物(LEGN.US)未提交6-K表格 違反納斯達克上市規則
金斯瑞生物科技(01548.HK)公布,其非全資附屬傳奇生物(LEGN.US)接獲納斯達克發出的通知,指傳奇生物由於未能向美國證監會提交關於截至去年6月底止季度的中期資產負債及損益表的6-K表格,目前已違反納斯達克上市規則。
根據納斯達克上市規則,傳奇生物須於截至去年6月底止季度後六個月內或不遲於去年12月31日前提交該等6-K表格。截至目前,傳奇生物尚未提交該規定的6-K表格。
公司指出,未合規通知對傳奇生物的美國存托股份上市地位並無直接影響。根據通知,傳奇生物可自通知之日起60日內或於今年3月7日前提交重新符合納斯達克上市規則的方案。若納斯達克採納傳奇生物的方案,納斯達克會給予傳奇生物自到期日起最多180個自然日或至今年6月29日的寬限期,以重新符合納斯達克上市規則。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.